Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Vaccine|October 31, 1998
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussisJ Storsaeter, H O Hallander, L Gustafsson, et al.
Scandinavian Journal of Infectious Diseases|September 11, 1999
Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in childrenH O Hallander, J Gnarpe, H Gnarpe, et al.
American Journal of Diseases of Children (1960)|November 1, 1991
Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitionsW C Blackwelder, J Storsaeter, P Olin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2001
How to make sense of pertussis immunogenicity dataP Olin, H O Hallander, L Gustafsson, et al.
Lancet (London, England)|December 11, 1997
Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis VaccinesP Olin, F Rasmussen, L Gustafsson, et al.
Developments in Biological Standardization|December 17, 1998
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccinationP Olin, H O Hallander, L Gustafsson, et al.
The New England Journal of Medicine|February 8, 1996
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccineL Gustafsson, H O Hallander, P Olin, et al.
Vaccine|March 16, 2000
Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of boosterM Tiru, H O Hallander, L Gustafsson, et al.
Journal of Clinical Microbiology|January 1, 1993
Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussisH O Hallander, E Reizenstein, B Renemar, et al.
Vaccine|March 10, 1998
Catch-up primary vaccination with acellular pertussis vaccines in 3-4-year-old children--reactogenicity and serological responseO Wärngård, L Nilsson, C Fåhraeus, et al.
Pageof 8